Knowledge of and concerns about long-acting reversible contraception among women in medication-assisted treatment for opioid use disorder

Contraception

Volumn 96, Issue 5, 2017, Pages 365-369

  Matusiewicz, Alexis K ^a,b   Melbostad, Heidi S ^a   Heil, Sarah H ^a,b  

^a UNIVERSITY OF VERMONT   (United States)

^b UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Long acting reversible contraception; Medication assisted treatment; Opioid use disorder; Unintended pregnancy

Indexed keywords

BUPRENORPHINE; METHADONE; ORAL CONTRACEPTIVE AGENT; CONTRACEPTIVE AGENT;

ADULT; ARTICLE; ATTITUDE TO HEALTH; BIRTH CONTROL; CONDOM USE; CONTRACEPTIVE BEHAVIOR; DRUG DEPENDENCE TREATMENT; FAMILY PLANNING; FEMALE; HUMAN; LONG-ACTING REVERSIBLE CONTRACEPTION; MAJOR CLINICAL STUDY; OPIATE ADDICTION; ORAL CONTRACEPTIVE USE; THERAPEUTIC ABORTION; UNPLANNED PREGNANCY; ADVERSE DEVICE EFFECT; BEHAVIOR; COGNITION; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE PREVALENCE SURVEY; DRUG IMPLANT; INTRAUTERINE CONTRACEPTIVE DEVICE; OPIATE SUBSTITUTION TREATMENT; PREGNANCY; VERMONT; YOUNG ADULT;

ADULT; COGNITIVE DISSONANCE; CONTRACEPTION BEHAVIOR; CONTRACEPTIVE AGENTS, FEMALE; CONTRACEPTIVE EFFECTIVENESS; CONTRACEPTIVE PREVALENCE SURVEYS; DRUG IMPLANTS; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; INTENTION; INTRAUTERINE DEVICES; LONG-ACTING REVERSIBLE CONTRACEPTION; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; PREGNANCY; PREGNANCY, UNPLANNED; VERMONT; YOUNG ADULT;

EID: 85028029219     PISSN: 00107824     EISSN: 18790518     Source Type: Journal    
DOI: 10.1016/j.contraception.2017.07.167     Document Type: Article

References (17)

1. Patrick, S.W., Davis, M.M., Lehmann, C.U., Cooper, W.O., Increasing incidence and geographic distribution of neonatal abstinence syndrome: United States 2009 to 2012. J Perinatol 35 (2015), 650–655.
2. Black, K.I., Stephens, C., Haber, P.S., Lintzeris, N., Unplanned pregnancy and contraceptive use in women attending drug treatment services. Aust N Z J Obstet Gynaecol 52 (2012), 146–150.
3. Burns, L., Conroy, E., Moore, E.A., Hutchinson, D., Haber, P.S., Psychosocial characteristics and obstetric health of women attending a specialist substance use antenatal clinic in a large metropolitan hospital. Int J Pediatr, 2011.
4. Heil, S.H., Jones, H.E., Arria, A., Kaltenbach, K., Coyle, M., Fischer, G., et al. Unintended pregnancy in opioid-abusing women. J Subst Abus Treat 40 (2011), 199–202.
5. Jones, H.E., O'Grady, K.E., Tuten, M., Reinforcement-based treatment improves the maternal treatment and neonatal outcomes of pregnant patients enrolled in comprehensive care treatment. Am J Addict 20 (2011), 196–204.
6. Trussell, J., Contraceptive failure in the United States. Contraception 83 (2011), 397–404.
7. Stoddard, A., McNicholas, C., Peipert, J.F., Efficacy and safety of long-acting reversible contraception. Drugs 71 (2011), 969–980.
8. Diedrich, J.T., Zhao, Q., Madden, T., Secura, G.M., Peipert, J.F., Three-year continuation of reversible contraception. Am J Obstet Gynecol 213 (2015), 662.e1–662.e8.
9. Terplan, M., Hand, D.J., Hutchinson, M., Salisbury-Afshar, E., Heil, S.H., Contraceptive use and method choice among women with opioid and other substance use disorders: a systematic review. Prev Med 80 (2015), 23–31.
10. Foster, D.G., Barar, R., Gould, H., Gomez, I., Nguyen, D., Biggs, M.A., Projections and opinions from 100 experts in long-acting reversible contraception. Contraception 92 (2015), 543–552.
11. National Campaign to Prevent Teen Pregnancy, Survey of reproductive and contraceptive knowledge [internet]. 2009, The National Campaign to Prevent Teen and Unplanned Pregnancy, Washington, DC [Available from: https://thenationalcampaign.org/sites/default/files/resource-supporting-download/survey_questionnaire.pdf; accessed 17.04.05].
12. Kaye, K., Sullentrop, K., Sloup, C., The fog zone: How misperceptions, magical thinking, and ambivalence put young adults at risk for unplanned pregnancy [internet]. 2009, The National Campaign to Prevent Teen and Unplanned Pregnancy, Washington, DC [Available from: https://thenationalcampaign.org/resource/fog-zone; accessed 17.04.05].
13. Guttmacher Institute [Internet], Contraceptive use in the United States. 2016, Guttmacher Institute, New York, NY [Available from: https://www.guttmacher.org/sites/default/files/factsheet/fb_contr_use_0.pdf; accessed 17.04.05].
14. [dataset] Centers for Disease Control [Internet], National Survey on family growth: Public use data files, codebooks, and documentation. 2013-2015, Centers for Disease Control, Atlanta, GA, 2016 [Available from: https://www.cdc.gov/nchs/nsfg/nsfg_2013_2015_puf.htm; Accessed: 17.04.05].
15. [dataset] The National Campaign to Prevent Teen and Unplanned Pregnancy [Internet], National survey of reproductive and contraceptive knowledge dataset. 2010, The National Campaign to Prevent Teen and Unplanned Pregnancy, Washington, DC [Data request available from: https://thenationalcampaign.org/resource/fog-zone-data-request; Accessed: 17.04.05].
16. Harper, C.C., Rocca, C.H., Thompson, K.M., Morfesis, J., Goodman, S., Darney, P.D., et al. Reductions in pregnancy rates in the USA with long-acting reversible contraception: a cluster randomised trial. Lancet 386 (2015), 562–568.
17. Black, K.I., Day, C.A., Improving access to long-acting contraceptive methods and reducing unplanned pregnancy among women with substance use disorders. Subst Abus 10:Suppl. 1 (2016), 27–33.